AERPIO THERAPEUTICS, INC.
Patent Owner
Stats
- 42 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- Feb 15, 2018 most recent publication
Details
- 42 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,725 Total Citation Count
- Aug 04, 2003 Earliest Filing
- 17 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0037,579 COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASESMar 17, 17Feb 08, 18[A61K, C07D]
2018/0022,741 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASESFeb 27, 17Jan 25, 18[A61K, C07D]
2017/0079,959 METHODS OF TREATING INTRAOCULAR PRESSURE WITH ACTIVATORS OF TIE-2Sep 22, 16Mar 23, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
RE46592 Human protein tyrosine phosphatase inhibitors and methods of useNov 11, 15Oct 31, 17[A61K, C07D]
9795594 Human protein tyrosine phosphatase inhibitors and methods of useFeb 05, 16Oct 24, 17[A61K, C07D]
9440963 Compositions, formulations and methods for treating ocular diseasesMar 14, 14Sep 13, 16[A61K, C07D]
9388135 Process for preparing N-benzyl-3-hydroxy-4-substituted-pyridin-2-(1H)-onesFeb 18, 15Jul 12, 16[C07D]
9284285 Human protein tyrosine phosphatase inhibitors and methods of useApr 14, 14Mar 15, 16[A61K, C07D]
9278930 Methods for increasing the stabilization of hypoxia inducible factor-αFeb 22, 15Mar 08, 16[A61K, C07D]
9174950 Compounds, compositions, and methods for preventing metastasis of cancer cellsMay 08, 14Nov 03, 15[A61K, A01N, C07D]
9126958 Human protein tyrosine phosphatase inhibitors and methods of useDec 12, 14Sep 08, 15[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0220,541 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASESAbandonedApr 14, 16Aug 04, 16[A61K]
2016/0220,540 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASESAbandonedApr 14, 16Aug 04, 16[A61K]
2016/0082,129 VE-PTP Extracellular Domain Antibodies Delivered by a Gene Therapy VectorAbandonedSep 23, 15Mar 24, 16[A61K, C12N]
2015/0050,277 COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASESAbandonedMar 14, 14Feb 19, 15[A61K, C07D]
2014/0288,134 COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASESAbandonedJun 10, 14Sep 25, 14[C07D]
2014/0044,707 ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES TEHREOFAbandonedAug 05, 13Feb 13, 14[C07K]
2013/0095,065 Methods for Treating Vascular Leak Syndrome and CancerAbandonedOct 15, 12Apr 18, 13[A61K, G01N, A61P]
2013/0023,542 HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USEAbandonedSep 25, 12Jan 24, 13[A61K, C07D, A61P]
2012/0129,847 COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASESAbandonedOct 05, 11May 24, 12[A61K, A61P]
2011/0268,694 METHODS FOR TREATING VASCULAR LEAK SYNDROMEAbandonedJan 12, 10Nov 03, 11[A61K, C12N, A61P]
2010/0056,610 HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERSAbandonedNov 02, 09Mar 04, 10[A61K, A61P]
2010/0016,336 HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USEAbandonedSep 11, 09Jan 21, 10[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.